Double-Blind, Randomized, Placebo-Controlled, Crossover Trial To Evaluate Induction Of Clinical Response In Patients With Moderate-Severe Crohn'S Disease Treated With Rifaximin

GASTROENTEROLOGY(2018)

引用 1|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要